User contributions

From WikiPathways

Search for contributions

 Show contributions of new accounts only
 IP Address or username: Namespace: all (Main) Talk User User talk WikiPathways WikiPathways talk Image Image talk MediaWiki MediaWiki talk Template Template talk Help Help talk Category Category talk Thread Thread talk Summary Summary talk Pw Old Pw Old Talk Pathway Pathway Talk Wishlist Wishlist Talk Portal Portal Talk

From year (and earlier): From month (and earlier): all January February March April May June July August September October November December

(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)

• 17:54, 24 May 2019 Homo sapiens:Interactome of polycomb repressive complex 2 (PRC2) ‎ (Modified description)
• 15:42, 20 May 2019 WikiPathways‎ (updating curator of the week)
• 22:35, 17 May 2019 CPTAC/Hallmark/Therapeutics‎
• 22:34, 17 May 2019 Homo sapiens:Cancer immunotherapy by PD-1 blockade‎ (Modified title)
• 22:34, 17 May 2019 CPTAC/FeaturedPathways‎ (Added new pathways)
• 22:19, 17 May 2019 Homo sapiens:Cancer immunotherapy by CTLA4 blockade‎ (Modified description)
• 22:15, 17 May 2019 Homo sapiens:Cancer immunotherapy by CTLA4 blockade‎ (updated details)
• 21:40, 17 May 2019 Homo sapiens:Cancer immunotherapy by PD-1 blockade‎ (Modified title)
• 21:40, 17 May 2019 CPTAC/Hallmark/Therapeutics‎ (adding cancer immunotherapy pathways)
• 21:25, 17 May 2019 Homo sapiens:Cancer immunotherapy by PD-1 blockade‎ (added xref)
• 21:18, 17 May 2019 Homo sapiens:Cancer immunotherapy by PD-1 blockade‎ (Modified description)
• 23:21, 16 May 2019 Homo sapiens:Cancer immunotherapy by PD-1 blockade‎ (added phosphosites)
• 23:04, 16 May 2019 Homo sapiens:Cancer immunotherapy by PD-1 blockade‎ (removed non-relevant and updated details)
• 21:32, 16 May 2019 Homo sapiens:Cancer immunotherapy by PD-1 blockade‎ (details added)
• 20:00, 16 May 2019 Homo sapiens:Interactions between immune cells and microRNAs in tumor microenvironment‎ (connected interaction)
• 19:58, 16 May 2019 Homo sapiens:Translation inhibitors in chronically activated PDGFRA cells‎ (connected interaction)
• 21:41, 15 May 2019 Homo sapiens:DNA damage response (only ATM dependent)‎ (updated legend, clarified phosphorylation of CTNNB1, unified fonts, cleanup)
• 21:00, 15 May 2019 Homo sapiens:DNA damage response (only ATM dependent)‎ (Modified description)
• 20:59, 15 May 2019 Homo sapiens:DNA damage response (only ATM dependent)‎ (Modified description)
• 21:17, 13 May 2019 ExRNA/FeaturedPathways‎ (removed deleted pathway) (top)
• 17:52, 13 May 2019 WikiPathways‎ (updating curator of the week)
• 21:31, 10 May 2019 Homo sapiens:Blood clotting and drug effects‎ (Modified description)
• 17:00, 10 May 2019 Updates‎ (adding may)
• 17:00, 10 May 2019 WikiPathways‎ (May 2019 download stats)
• 16:53, 10 May 2019 Download Pathways‎ (update to may download)
• 00:23, 7 May 2019 Homo sapiens:Cancer immunotherapy by PD-1 blockade‎ (added lit ref)
• 00:21, 7 May 2019 Homo sapiens:Cancer immunotherapy by PD-1 blockade‎ (Modified description)
• 00:19, 7 May 2019 Homo sapiens:Cancer immunotherapy by PD-1 blockade‎ (Modified description)
• 18:09, 6 May 2019 WikiPathways‎ (updating curator of the week)
• 19:23, 3 May 2019 Homo sapiens:Cancer immunotherapy by PD-1 blockade‎ (Modified description)
• 19:21, 3 May 2019 Homo sapiens:Cancer immunotherapy by CTLA4 blockade‎ (Modified description)
• 19:17, 3 May 2019 Homo sapiens:Cancer immunotherapy by CTLA4 blockade‎ (Modified description)
• 18:55, 3 May 2019 Homo sapiens:Cancer immunotherapy by CTLA4 blockade‎ (Ontology Term : 'adaptive immune response pathway' added !)
• 18:54, 3 May 2019 Homo sapiens:Cancer immunotherapy by CTLA4 blockade‎ (Ontology Term : 'T cell' added !)
• 18:54, 3 May 2019 Homo sapiens:Cancer immunotherapy by CTLA4 blockade‎ (decreased board size)
• 18:53, 3 May 2019 Homo sapiens:Cancer immunotherapy by PD-1 blockade‎ (Ontology Term : 'PW:0000023' removed !)
• 18:52, 3 May 2019 Homo sapiens:Cancer immunotherapy by PD-1 blockade‎ (Ontology Term : 'adaptive immune response pathway' added !)
• 18:52, 3 May 2019 Homo sapiens:Cancer immunotherapy by PD-1 blockade‎ (Ontology Term : 'immune response pathway' added !)
• 18:51, 3 May 2019 Homo sapiens:Cancer immunotherapy by PD-1 blockade‎ (Ontology Term : 'cancer' added !)
• 18:51, 3 May 2019 Homo sapiens:Cancer immunotherapy by PD-1 blockade‎ (Ontology Term : 'T cell' added !)
• 18:48, 3 May 2019 N Homo sapiens:Cancer immunotherapy by PD-1 blockade‎ (New pathway)
• 21:28, 2 May 2019 Homo sapiens:Cancer immunotherapy by CTLA4 blockade‎ (Modified description)
• 21:23, 2 May 2019 Homo sapiens:Cancer immunotherapy by CTLA4 blockade‎ (Ontology Term : 'professional antigen presenting cell' added !)
• 21:20, 2 May 2019 Homo sapiens:Cancer immunotherapy by CTLA4 blockade‎ (Ontology Term : 'immune response pathway' added !)
• 21:20, 2 May 2019 Homo sapiens:Cancer immunotherapy by CTLA4 blockade‎ (Ontology Term : 'cancer' added !)
• 21:18, 2 May 2019 N Homo sapiens:Cancer immunotherapy by CTLA4 blockade‎ (New pathway)
• 18:33, 29 April 2019 WikiPathways‎ (updating curator of the week)
• 17:57, 23 April 2019 ExRNA/FeaturedPathways‎ (updated reference to gpml)
• 20:53, 5 April 2019 Homo sapiens:Chromosomal and microsatellite instability in colorectal cancer ‎ (Added lit refs)
• 20:45, 5 April 2019 Homo sapiens:Epithelial to mesenchymal transition in colorectal cancer‎ (unified node size and added lit refs for mutations)

(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)